Showing results (301-310 of 831) with videos related to

Sort By:
Pageof 84
Ugeskrift for Laeger|October 3, 2018
[Heart failure often accompanies diabetes mellitus]Martin Høhrmann Hangaard, Peter Rossing, Jan Skov Jensen, et al.
Diabetes Research and Clinical Practice|November 25, 2015
Statins are independently associated with increased HbA1c in type 1 diabetes--The Thousand & 1 StudyMagnus Thorsten Jensen, Henrik Ullits Andersen, Peter Rossing, et al.
Blood Pressure Monitoring|April 3, 2013
Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: comparison of the BPro and SphygmoCor devicesSimone Theilade, Tine W Hansen, Christel Joergensen, et al.
Acta Diabetologica|October 3, 2014
Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffnessSigne Rosenlund, Simone Theilade, Tine Willum Hansen, et al.
Diabetes, Obesity & Metabolism|March 12, 2026
Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney DiseaseM Luiza Caramori, Enrico Repetto, Christopher Perkins, et al.
Ugeskrift for Laeger|June 16, 2009
[Hypertension in patients with diabetes]Per Løgstrup Poulsen, Klavs Würgler Hansen, Peter Haulund Gaede, et al.
European Heart Journal|March 23, 2011
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trialsFrank A Holtkamp, Dick de Zeeuw, Pieter A de Graeff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2003
Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibitionBirger Hesse, Christian Meyer, Flemming S Nielsen, et al.
Diabetologia|November 4, 2017
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trialJelena P Seferovic, Marc A Pfeffer, Brian Claggett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 12, 2013
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT)Hiddo J Lambers Heerspink, Misghina Weldegiorgis, Lesley A Inker, et al.
Pageof 84